APA

Kashyap T., Argueta C., Aboukameel A., Unger T. J., Klebanov B., Mohammad R. M., Muqbil I., Azmi A. S., Drolen C., Senapedis W., Lee M., Kauffman M., Shacham S. & Landesman Y. (20180223). Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death. : Oncotarget.

Chicago

Kashyap Trinayan, Argueta Christian, Aboukameel Amro, Unger Thaddeus John, Klebanov Boris, Mohammad Ramzi M, Muqbil Irfana, Azmi Asfar S, Drolen Claire, Senapedis William, Lee Margaret, Kauffman Michael, Shacham Sharon and Landesman Yosef. 20180223. Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death. : Oncotarget.

Harvard

Kashyap T., Argueta C., Aboukameel A., Unger T. J., Klebanov B., Mohammad R. M., Muqbil I., Azmi A. S., Drolen C., Senapedis W., Lee M., Kauffman M., Shacham S. and Landesman Y. (20180223). Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death. : Oncotarget.

MLA

Kashyap Trinayan, Argueta Christian, Aboukameel Amro, Unger Thaddeus John, Klebanov Boris, Mohammad Ramzi M, Muqbil Irfana, Azmi Asfar S, Drolen Claire, Senapedis William, Lee Margaret, Kauffman Michael, Shacham Sharon and Landesman Yosef. Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death. : Oncotarget. 20180223.